Evidence-based guideline update: Medical treatment of infantile spasms: Report of the guideline development subcommittee of the American academy of neurology and the practice committee of the child neurology society

Neurology

Volumn 78, Issue 24, 2012, Pages 1974-1980

  Go, C Y ^a   MacKay, M T ^b   Weiss, S K ^a   Stephens, D ^a   Adams Webber, T ^a   Ashwal, S ^c   Snead III, O C ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; PREDNISOLONE; VIGABATRIN;

ARTICLE; CORTICOSTEROID THERAPY; DRUG MEGADOSE; EMBASE; EVIDENCE BASED PRACTICE; HORMONAL THERAPY; HUMAN; INFANTILE SPASM; LOW DRUG DOSE; MEDLINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

EID: 84863604188     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318259e2cf     Document Type: Article

References (40)

1. Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001;23:539-541.
2. Ludvigsson P, Ólafsson E, Sigurardóttir S, Hauser WA. Epidemiologic features of infantile spasms in Iceland. Epilepsia 1994;35:802-805.
3. Trevathan E, Murphy CC, Yeargin-Allsopp M. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 1999;40:748-751.
4. Hattori H. Spontaneous remission of spasms in West syndrome: implications of viral infection. Brain Dev 2001;23: 705-707.
5. Hrachovy RA, Glaze DG, Frost JD Jr. A retrospective study of spontaneous remission and long-term outcome in patients with infantile spasms. Epilepsia 1991;32:212-214.
6. Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62:1668-1681.
7. Elterman RD, Shields WD, Mansfield KA, Nakagawa J. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001;57:1416-1421.
8. Vigevano F, Cilio MR. Vigabatrin versus ACTH as firstline treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-1274.
9. Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD. Vigabatrin: 2008 update. Epilepsia 2009;50: 163-173.
10. Elterman RD, Shields WD, Bittman RM, Torri SA, Sagar SM, Collins SD. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial. J Child Neurol 2010;25:1340-1347.
11. Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010;51:2175-2189.
12. Fukuyama Y. The Japanese scheme of ACTH therapy in West syndrome. Epilepsia 2010;51:2216-2218; author reply 2221.
13. Riikonen R. A European perspective: comments on "Infantile spasms: a U.S. consensus report." Epilepsia 2010; 51:2215-2216; author reply 2221.
14. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
15. Baram TZ, Mitchell WG, Tournay A. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996; 97:375-379.
16. Hrachovy RA, Frost JD Jr, Kellaway P, Zion TE. Doubleblind study of ACTH vs prednisone therapy in infantile spasms. J Pediatr 1983;103:641-645.
17. Lombroso CT. A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia 1983;24: 135-158.
18. Hrachovy RA, Frost JD Jr, Kellaway P. A controlled study of prednisone therapy in infantile spasms. Epilepsia 1979; 20:403-477.
19. Yamamoto H, Asoh M, Murakami H, et al. Liposteroid (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy. Pediatr Neurol 1998;18:415-419.
20. Snead OC, Benton JW, Myers GJ. ACTH and prednisone in childhood seizure disorders. Neurology 1983;33:966-970.
21. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773-1778.
22. Mytinger JR, Quigg M, Taft WC, Buck ML, Rust RS. Outcomes in treatment of infantile spasms with pulse methylprednisolone. J Child Neurol 2010;25:948-953.
23. Haberlandt E, Weger C, Sigl SB, et al. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes. Pediatr Neurol 2010;42:21-27.
24. Hrachovy RA, Frost JD Jr, Glaze DG. High-dose, longduration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr 1994;124:803-806.
25. Yanagaki S, Oguni H, Hayashi K. A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev 1999;21:461-467.
26. Hrachovy RA, Frost JD Jr, Kellaway P. A controlled study of ACTH therapy in infantile spasms. Epilepsia 1980;21: 631-636.
27. Cossette P, Riviello JJ, Carmant L. ACTH versus vigabatrin in infantile spasms: a retrospective study. Neurology 1999;52:1691-1694.
28. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005;4:712-717.
29. Askalan R, Mackay M, Brian J, et al. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. J Child Neurol 2003;18:165-170.
30. Fisher E, Siemes H, Pund R. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia 1992;33:165-171.
31. Siemes H, Spohr H-L, Michael T. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia 1988;29:553-560.
32. Chamberlain MC. Nitrazepam for refractory infantile spasms and the Lennox-Gastaut syndrome. J Child Neurol 1996;11:31-34.
33. Volzke E, Doose H, Stephan E. The treatment of infantile spasms and hypsarrhythmia with Mogadon. Epilepsia 1967;8:64-70.
34. Ohtsuka Y, Matsuda M, Ogino T. Treatment of the West syndrome with high-dose pyridoxal phosphate. Brain Dev 1987;9:418-421.
35. Pietz J, Benninger C, Schafer H. Treatment of infantile spasms with high-dosage vitamin B6. Epilepsia 1993;34:757-763.
36. Suzuki Y, Nagai T, Ono J. Zonisamide monotherapy in newly diagnosed infantile spasms. Epilepsia 1997;38:1035-1038.
37. Yanagaki S, Oguni H, Yoshii K, et al. Zonisamide for West syndrome: a comparison of clinical responses among different titration rate. Brain Dev 2005;27:286-290.
38. Echenne B, Dulac O, Parayre-Chanez MJ. Treatment of infantile spasms with intravenous gamma-globulins. Brain Dev 1991;13:313-319.
39. Matsumoto A, Kumagai T, Takeuchi T. Factors influencing effectiveness of thyrotropin-releasing hormone therapy for severe epilepsy in childhood: significance of serum prolactin levels. Epilepsia 1989;30:45-49.
40. Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998;39:1324-1328.